Christian P. Kalberer

Author

Also Known As

C Kalberer, C P Kalberer, C. Kalberer, C. P. Kalberer, C.P. Kalberer, CHRISTIAN KALBERER, CP Kalberer, Christian Kalberer, Christian P Kalberer, Christian P. Kalberer

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

University Hospital of Basel University of Zurich University of Basel Karolinska Institutet BC Cancer Agency

About

Christian P. Kalberer is an author at University Hospital of Basel specializing in immunology, medicine, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1K
2	Immunology	12	12	1K
3	Cell Biology	10	10	893
4	Cellular Therapies	4	4	318
5	Allergy	3	3	391

Christian P. Kalberer

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
On the role of antigen in maintaining cytotoxic T-cell memory. Thomas M. Kündig, M F Bachmann, S Oehen, Proceedings of the National Academy of Sciences VaccinationAllergyMedicinePersistent AntigenPrecursor Frequencies	1996	232
NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities Stefan Diermayr, Heike Himmelreich, Bojana Müller-Durovic, Blood	2007	211
Ligands for natural killer cell–activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias Pegah Nowbakht, Mihai-Constantin S. Ionescu, A Rohner, Blood	2005	193
A Dual Role for Src Homology 2 Domain–Containing Inositol-5-Phosphatase (Ship) in Immunity Cheryl D. Helgason, Christian P. Kalberer, Jacqueline E. Damen, The Journal of Experimental Medicine	2000	150
Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice. Luc Reininger, Thomas Winkler, Christian P. Kalberer, The Journal of Experimental Medicine HistocompatibilitySerum ImmunoglobulinImmunologyHumoral ResponsePathology	1996	110
Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis A Rohner, Ulrich Langenkamp, Uwe Siegler, Leukemia Research Hematological MalignancyCell TherapyImmunologyCell DeathAutoimmunity	2007	107
Advances in clinical NK cell studies: Donor selection, manufacturing and quality control Ulrike Koehl, Christian P. Kalberer, Jan Spanholtz, OncoImmunology Cell TherapyImmunologyImmunoeditingPathologyNk Cells	2015	100
Formalin inactivation of vesicular stomatitis virus impairs T-cell- but not T-help-independent B-cell responses Martin F. Bachmann, Thomas M. Kündig, Christian P. Kalberer, Journal of Virology Humoral ResponseImmunologyEarly Immunoglobulin MAntigen ProcessingCd4 T Cell Responses	1993	90
Vaccination with two different vaccinia recombinant viruses: long-term inhibition of secondary vaccination Thomas M. Kündig, Christian P. Kalberer, Hans Hengartner, Vaccine VaccinationVaccinologyVaccine DevelopmentMedicineVaccine Target	1993	90
Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients Uwe Siegler, Sandrine Meyer‐Monard, Simon Jörger, Cytotherapy Multiple InfusionsCell TherapyMedicineMalignant Blood DisorderStem Cell Transplantation	2010	90

Page 1